In addition to Trim63, our results on Fos are also consistent with previous reports, where the inhibition of Fos suppressed colon carcinoma tumor growth in athymic mice as well as the progression of ovarian and breast cancer (Pandey et al., 2012; Oliveira-Ferrer et al., 2014; Li et al., 2019). Here, FOS is linked to breast carcinoma.